Amerise Biosciences Current Share Price | Amerise Biosciences Stock Screener
AMERISE
Plastic Products - Industrial
Amerise Biosciences Current Stock Price Today
Live Share Price BSE
₹0.84
▲
0.04 (5.00%)
As of September 18, 2026, the live Amerise Biosciences share price (BSE: AMERISE) is ₹0.84, up 5.00% from the previous close, with shares trading between ₹0.79 and ₹0.84 in today's trading session, and a 52-week range of ₹0.50–₹1.01.
Browse AMERISE complete financial statements to support your investment research.
Use the Amerise Biosciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Amerise Biosciences Market Cap
₹5.47 Cr.
AMERISE P/E Ratio (TTM)
-
Amerise Biosciences P/B Ratio
1.00
EPS (TTM)
-
Dividend Yield
-
Debt to Equity
-
AMERISE 52 Week High
₹1.01
Amerise Biosciences 52 Week Low
₹0.50
Operating Margin
-
Profit Margin
-
AMERISE Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹9.00
Total Equity
₹5.00
Amerise Biosciences Current Share Price Chart
Track the current Amerise Biosciences share price and stock price with an interactive chart. Analyse AMERISE price trends, trading volume, historical performance, and volatility across different timeframes — the complete Amerise Biosciences stock quote in one place.
Amerise Biosciences Company Profile - Fundamental Screener
Screen Amerise Biosciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for AMERISE shares.
Sector
Industrial Products
Industry
Plastic Products - Industrial
Sub-Sector
Plastic Products - Industrial
Segment
E
ISIN
INE673C01020
Amerise Biosciences Balance Sheet Screener
Screen AMERISE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 9 | 5 | 6 | 12 | 6 | 6 | 6 | 6 | 6 | 7 |
| Current Assets | 0 | 0 | 0 | 6 | 0 | 0 | 5 | 3 | 3 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 5 | 5 | 6 | 6 | 5 | 5 | 6 | 6 | 6 | 7 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | -1 | -1 | -1 | -1 | -2 | -1 | -1 | -1 | -1 | 0 |
Amerise Biosciences Income Statement Screener - Profit & Revenue Analysis
Screen Amerise Biosciences income statement and profit fundamentals.
Analyze AMERISE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Amerise Biosciences share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
| Operating Profit % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
| EPS | 0.00 | 0.00 | 0.00 | -0.02 | -0.02 | 0.08 | -0.05 | -0.02 | 0.00 | 0.00 | -0.14 | 0.00 | -0.01 |
Amerise Biosciences Cash Flow Screener - Liquidity Fundamentals
Screen AMERISE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 3 | 0 | 0 | 0 | 0 | 5 | -2 | 0 | -4 | 1 |
| Investing Activities | -3 | 0 | 0 | 0 | 0 | -5 | 2 | 0 | 4 | -1 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Amerise Biosciences Shareholding Pattern Screener
See Amerise Biosciences shareholding pattern with promoter, FII, and DII holdings.
Check Amerise Biosciences promoter holding and ownership changes for AMERISE on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 71.97% | 69.90% | 72.09% | 72.04% | 72.04% | 72.01% | 72.32% | 72.28% |
| Other Holding | 28.03% | 30.10% | 27.91% | 27.96% | 27.96% | 27.99% | 27.68% | 27.72% |
| Shareholder Count | 34,519 | 33,848 | 36,595 | 36,217 | 35,676 | 35,180 | 23,485 | 23,323 |
Amerise Biosciences Share Dividend Screener - Share Yield Analysis
Check Amerise Biosciences dividend history with payout and yield data.
View Amerise Biosciences dividend details including ex-dates and amounts for AMERISE stock.
Amerise Biosciences Stock Index Membership
See which indices include Amerise Biosciences stock.
Check AMERISE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Amerise Biosciences Market Events Screener - Corporate Actions
Get Amerise Biosciences corporate actions including splits, bonuses, and buybacks.
Check Amerise Biosciences stock events that may affect AMERISE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-24 | 2026-09-24 | Annual General Meeting | NA | 3.75% |
| 2026-08-03 | 2026-08-03 | Quarterly Result Announcement | NA | 14.77% |
| 2026-05-05 | 2026-05-05 | Quarterly Result Announcement | NA | 1.41% |
| 2026-02-02 | 2026-02-02 | Quarterly Result Announcement | NA | -6.15% |
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | -3.03% |
| 2025-09-23 | 2025-09-23 | Annual General Meeting | NA | -9.09% |
| 2025-07-24 | 2025-07-24 | Quarterly Result Announcement | NA | -5.06% |
| 2025-05-19 | 2025-05-19 | Quarterly Result Announcement | NA | 1.27% |
| 2025-02-03 | 2025-02-03 | Quarterly Result Announcement | NA | -7.27% |
| 2024-10-22 | 2024-10-22 | Quarterly Result Announcement | NA | 2.33% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 0.00% |
| 2021-08-16 | 2021-08-16 | Change Of Name | NA | 0.00% |
Amerise Biosciences Competitors Screener - Peer Comparison
Screen AMERISE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Supreme Industries | 42,737 | 43.07 | 11,263 | 7.22% | 954 | 38.13 |
| Astral | 37,917 | 68.13 | 6,616 | 12.64% | 535 | 32.69 |
| Garware Hi-Tech Films | 16,080 | 41.40 | 2,185 | 0.98% | 338 | 45.13 |
| Shaily Engineering Plastics | 15,084 | 87.70 | 991 | 25.54% | 179 | 50.69 |
| Finolex Industries | 9,521 | 15.83 | 4,325 | -1.45% | 599 | 35.56 |
| Time Technoplast | 8,925 | 18.33 | 6,114 | 11.94% | 477 | 35.78 |
| Kingfa Science & Technology | 8,398 | 37.30 | 1,996 | 13.76% | 186 | 65.01 |
| Prince Pipes & Fittings | 2,948 | 30.26 | 2,609 | 2.82% | 75 | 35.96 |
| Apollo Pipes | 2,444 | -171.23 | 1,115 | -6.03% | 5 | 42.66 |
| Jain Irrigation Systems | 2,123 | -30.94 | 6,413 | 10.70% | -40 | 50.71 |
Amerise Biosciences Company Announcements - News Screener
Screen AMERISE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-01 | Reg. 34 (1) Annual Report. | - |
| 2026-09-01 | Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-09-01 | Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-18 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-03 | Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") | - |
| 2026-08-03 | Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") | - |
| 2026-08-03 | Board Meeting Outcome for Outcome Of Board Meeting Held On 3Rd August 2026 | - |
| 2026-07-29 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-22 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-21 | Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting. | - |
| 2026-07-17 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-17 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-09 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-11 | Closure of Trading Window | - |
| 2026-06-05 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-05-05 | Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") | - |
| 2026-05-05 | Board Meeting Outcome for Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March 2026 And Outcome Of The Board Meeting Held On Tuesday 5Th May 2026. | - |
| 2026-05-05 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-04-29 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |